MetaCap

Bio-Rad Laboratories (BIO) vs Mettler-Toledo International (MTD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Mettler-Toledo International (MTD) has outperformed Bio-Rad Laboratories (BIO) over the past year, gaining 14.8% versus a gain of 13.3%. Over five years, MTD leads with a +11.4% price change compared with -52.2% for BIO. Mettler-Toledo International is the larger company by market cap ($33.15 billion vs $9.65 billion), about 3.4 times the size.

On valuation, Mettler-Toledo International trades at a lower forward P/E (31.3x vs 36.2x for Bio-Rad Laboratories). Bio-Rad Laboratories converts more of its revenue into profit, with a net margin of 29.4% versus 21.6%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BIO+13.32%MTD+14.77%
+26%-3%-32%
Nov 21, 20251 yearNov 20, 2026
BIO-53.79%MTD+7.40%
+16%-30%-76%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BIO versus MTD key metrics
MetricBIOMTD
Share price$358.90$1,666.88
Market cap$9.65B$33.15B
1-day change-2.34%-2.27%
YTD return+18.45%+19.56%
1-year return+13.32%+14.77%
5-year return-52.16%+11.37%
P/E ratio (TTM)9.5436.18
Forward P/E36.2331.32
EPS (TTM)$37.64$46.07
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$2.58B$4.03B
Revenue growth (YoY)+0.65%+3.98%
Net income (latest FY)$759.90M$869.19M
Gross margin51.87%59.37%
Operating margin1.83%—
Net margin29.42%21.59%
52-week high$396.23$1,806.58
52-week low$236.73$1,023.05
Distance from 52-week high-9.42%-7.73%
Analyst consensusholdhold
Avg. price target upside-0.62%+4.24%
Average volume257.70K192.63K
Shares outstanding21.83M19.89M
Employees7,45016,600
SectorIndustrialsIndustrials
IndustryBiotechnology: Laboratory Analytical InstrumentsBiotechnology: Laboratory Analytical Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Mettler-Toledo International is about 3.4 times larger than Bio-Rad Laboratories by market value ($33.15B vs $9.65B).
  • Mettler-Toledo International trades at a higher earnings multiple (36.2x vs 9.5x trailing P/E).
  • Bio-Rad Laboratories is more profitable, keeping 29.4 cents of every revenue dollar as net income versus 21.6 cents for Mettler-Toledo International.

About Bio-Rad Laboratories

BIO stock →

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally.

Industrials · Biotechnology: Laboratory Analytical Instruments · 7,450 employees

About Mettler-Toledo International

MTD stock →

Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally.

Industrials · Biotechnology: Laboratory Analytical Instruments · 16,600 employees

BIO vs MTD FAQ

Which is bigger, Bio-Rad Laboratories or Mettler-Toledo International?

Mettler-Toledo International (MTD) is larger, with a market capitalization of $33.15B compared with $9.65B for Bio-Rad Laboratories (BIO).

Which stock has performed better over the past year, BIO or MTD?

MTD returned +14.77% over the past 12 months, compared with +13.32% for BIO (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, BIO or MTD?

BIO has the lower trailing P/E at 9.5, versus 36.2 for MTD. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Are Bio-Rad Laboratories and Mettler-Toledo International in the same industry?

Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.

More comparisons